Aurobindo Pharma consolidated net profit rises 39.54% in the June 2019 quarter

Sales rise 28.11% to Rs 5356.84 crore

Net profit of Aurobindo Pharma rose 39.54% to Rs 635.83 crore in the quarter ended June 2019 as against Rs 455.66 crore during the previous quarter ended June 2018. Sales rose 28.11% to Rs 5356.84 crore in the quarter ended June 2019 as against Rs 4181.56 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales5356.844181.56 28 OPM %21.4017.00 -PBDT1117.00725.66 54 PBT876.14571.13 53 NP635.83455.66 40

Powered by Capital Market - Live News